Latest News
Global Markets North American Markets Canada’s TSX rose on the back of global market momentum as news broke that Donald Trump had reclaimed the U.S. presidency. Investor sentiment was buoyed by expectations of pro-business policies, with the S&P 500 and Dow futures surging to record highs. This optimism in the...
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
Knowing these will help you avoid making suboptimal investing decisions.
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
Let's look beyond this piece of bad news from regulators.
How Bad Is This News for Novavax?
Novavax stock fell 20% in one trading session on the news.
Should You Buy Novavax Stock After This Regulatory Win?
The biotech continues to earn important wins, but is it enough?
Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?
Regulators recently approved an updated COVID shot from Novavax.
Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
Don't be too quick to jump on the Wall Street bandwagon.
Novavax Inc (NVAX) recently released its quarterly earnings report for the period ending June 30, 2024. As a key player in the biotechnology sector, Novavax’s performance and management analysis are critical for stakeholders and investors. Key Insights from Novavax’s Q2 Reports: Below are the key findings from the Novavax’s Q2...
Where Will Novavax Be in 5 Years?
Its been a good year so far for the biotech, but how long can it keep the momentum going?
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
/CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, announced that it has filed for...
Where Will Novavax Be in 1 Year?
We will know a lot more about the vaccine maker's long-term prospects in 12 months.
Even if you can see it coming, you’re never going to time it just right
Is It Too Late to Buy Novavax Stock?
Shares of the vaccine maker are trading up 230% this year.
Shares of Novavax (NVAX: NSD) plummeted as the initial wave of panic surrounding COVID-19 subsided. Investors rushed to buy stocks of companies that delivered lifesaving vaccines early in the pandemic. However, Novavax's vaccine candidate was delayed, causing its stock price to tumble. Novavax Stock: A Second Wind in a New...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These pharma and biotech players could become long-term winners.
Why Vaccine Stocks Rallied This Week
A bird flu outbreak could spur demand for vaccines from these key players, but is it likely?
Better Buy: Inovio Pharmaceuticals vs. Novavax
Both biotechs have been struggling for a while, but there might be some hope for them.
3 Things You Need to Know If You Buy Novavax Today
The vaccine maker's recovery story is looking brighter.
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
The biotech still hasn't lost momentum.
Is Novavax Stock a Buy?
Can Novavax's stock continue soaring?
Could Novavax Become the Next Moderna?
Sanofi believes in Novavax's vaccine strengths...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
This coronavirus vaccine maker entered the market behind rivals.
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
A potentially very lucrative arrangement with a peer doesn't necessarily make the company a buy.
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
These two healthcare stocks may be deeply undervalued.